Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci - PubMed (original) (raw)
. 1994 Dec 15;153(12):5607-17.
Affiliations
- PMID: 7989760
Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci
P Sideras et al. J Immunol. 1994.
Abstract
Btk is a cytoplasmic protein tyrosine kinase (PTK) that has been directly implicated in the pathogenesis of X-linked agammaglobulinaemia (XLA) in humans and X-linked immunodeficiency (Xid) in mice. We have isolated phage and cosmid clones that allowed us to deduce the genomic structure of mouse and human Btk loci. The mouse and human genes are contained within genomic regions that span approximately 43.5 kb and 37.5 kb, respectively. Both loci contain 18 coding exons ranging between 55 and 560 bp in size with introns ranging in size from 164 bp to approximately 9 kb. The 5'-untranslated regions are encoded by single exons located approximately 9 kb upstream of the first coding exon. Exon 18 encodes for the last 23 carboxyl-terminal amino acids and the entire 3'-untranslated region. The location of intron/exon boundaries in the catalytic domains of the mouse and human Btk loci differs from that found in other described sub-families of intracellular PTKs, namely that of Src, Fes/Fer, Csk, and Abl/Arg. This observation is consistent with the classification of Btk together with the recently characterized kinases, Tec and Itk, into a separate sub-family of cytoplasmic PTKs. Putative transcription initiation sites in the mouse and human Btk loci have been determined by using the rapid amplification of cDNA ends assay. Similar to many other PTK specific genes, the putative Btk promoters lack obvious TATAA and CAAAT motifs. Putative initiator elements and potential binding sites for Ets (PEA-3), zeste, and PuF transcription factors are located within the 300 bp which are located upstream of the major transcription start site in both species. These sequences can mediate promoter activity when placed upstream of a promotorless chloramphenicol acetyl transferase reporter gene in an orientation-dependent manner. The present analysis will significantly facilitate the mutational analyses of patients with XLA and the further characterization of the function and regulation of the Btk molecule.
Similar articles
- Characterization of the human CSK locus.
Bräuninger A, Karn T, Strebhardt K, Rübsamen-Waigmann H. Bräuninger A, et al. Oncogene. 1993 May;8(5):1365-9. Oncogene. 1993. PMID: 7683131 - Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia.
Schuster V, Seidenspinner S, Kreth HW. Schuster V, et al. Am J Med Genet. 1996 May 3;63(1):318-22. doi: 10.1002/(SICI)1096-8628(19960503)63:1<318::AID-AJMG53>3.0.CO;2-N. Am J Med Genet. 1996. PMID: 8723128 - Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
Lindvall JM, Blomberg KE, Väliaho J, Vargas L, Heinonen JE, Berglöf A, Mohamed AJ, Nore BF, Vihinen M, Smith CI. Lindvall JM, et al. Immunol Rev. 2005 Feb;203:200-15. doi: 10.1111/j.0105-2896.2005.00225.x. Immunol Rev. 2005. PMID: 15661031 Review. - The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia.
Rohrer J, Parolini O, Belmont JW, Conley ME, Parolino O [corrected to Parolini O]. Rohrer J, et al. Immunogenetics. 1994;40(5):319-24. doi: 10.1007/BF01246672. Immunogenetics. 1994. PMID: 7927535 - X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease.
Mattsson PT, Vihinen M, Smith CI. Mattsson PT, et al. Bioessays. 1996 Oct;18(10):825-34. doi: 10.1002/bies.950181009. Bioessays. 1996. PMID: 8885720 Review.
Cited by
- X-linked agammaglobulinemia.
Conley ME, Rohrer J, Minegishi Y. Conley ME, et al. Clin Rev Allergy Immunol. 2000 Oct;19(2):183-204. doi: 10.1385/CRIAI:19:2:183. Clin Rev Allergy Immunol. 2000. PMID: 11107501 Review. No abstract available. - Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage.
Hendriks RW, de Bruijn MF, Maas A, Dingjan GM, Karis A, Grosveld F. Hendriks RW, et al. EMBO J. 1996 Sep 16;15(18):4862-72. EMBO J. 1996. PMID: 8890160 Free PMC article. - X-Linked Agammagobulinemia in a Large Series of North African Patients: Frequency, Clinical Features and Novel BTK Mutations.
Aadam Z, Kechout N, Barakat A, Chan KW, Ben-Ali M, Ben-Mustapha I, Zidi F, Ailal F, Attal N, Doudou F, Abbadi MC, Kaddache C, Smati L, Touri N, Chemli J, Gargah T, Brini I, Bakhchane A, Charoute H, Jeddane L, El Atiqi S, El Hafidi N, Hida M, Saile R, Alj HS, Boukari R, Bejaoui M, Najib J, Barbouche MR, Lau YL, Mellouli F, Bousfiha AA. Aadam Z, et al. J Clin Immunol. 2016 Apr;36(3):187-94. doi: 10.1007/s10875-016-0251-z. Epub 2016 Mar 1. J Clin Immunol. 2016. PMID: 26931785 - Splice-correction strategies for treatment of X-linked agammaglobulinemia.
Bestas B, Turunen JJ, Blomberg KE, Wang Q, Månsson R, El Andaloussi S, Berglöf A, Smith CI. Bestas B, et al. Curr Allergy Asthma Rep. 2015 Mar;15(3):510. doi: 10.1007/s11882-014-0510-0. Curr Allergy Asthma Rep. 2015. PMID: 25638286 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases
Miscellaneous